Enclosed.

Listed Co AcquisitionOpen Offer TriggeredStrategic Transactions View source PDF Explain this filing

CAMLINFINE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.1%Reaction day

₹131.60

prior close

₹132.60

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.1%-1.0% vs market

Specialty Chemicals peers, median of 94sector-0.1%-1.0% vs sector

On the reaction day the stock moved 1.0 pts less than Nifty Microcap 250 and 1.0 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.7

10m

-2.0

15m

-1.0

30m

+0.2

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.1-0.1-1.0-0.1-1.0

Next day

+4.1+1.5+2.6+1.4+2.7

+3.6+3.1+0.5+2.6+1.0

+0.4+3.0-2.6+3.1-2.7

-4.4+1.6-6.0+1.1-5.5

-8.2-1.6-6.6-0.9-7.3

-6.5-0.6-5.9+0.4-7.0

15d

-7.7+2.2-9.8+0.6-8.3

+0.7+2.6-1.9-1.8+2.5

+1.1+8.9-7.8+2.6-1.6

-2.4+11.4-13.8+5.6-8.0

UpDownMarket · Nifty Microcap 250Sector · Specialty Chemicals peers, median of 94Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Camlin Fine Sciences has filed a draft simplified cash tender offer with the French Stock Markets Authority (AMF) to acquire the remaining shares of Vinpai that it does not already own. The company initially acquired a majority stake (78.68% of share capital) in November 2025 at EUR 3.60 per share and now holds 83.82% after converting convertible bonds. The new tender offer targets the remaining shares at the same price of EUR 3.60 per share. An independent expert (Crowe HAF) has confirmed the offer is fair for minority shareholders, and Vinpai's Board has unanimously given a favorable opinion. Importantly, CFSL states it no longer intends to pursue a squeeze-out procedure.

Likely market impact

This acquisition move could be positive for CFSL shareholders as it strengthens control over Vinpai, though the market may watch for dilution risks or integration challenges with the French subsidiary.